Stockholders' Equity | Note 5. Stockholders' Equity Dividends On January 18, 2023, our board of directors declared a quarterly dividend of $0.35 per share of common stock to be paid in cash on March 2, 2023 to shareholders of record at the close of business on February 2, 2023. We paid aggregate annual cash dividends per share of $1.24 and $1.12 in 2022 and 2021, respectively. In 2020, we paid aggregate annual cash dividends per share of $1.40, which included a special, one-time dividend of $0.40 per share. Stock Options Effective January 3, 2023, the compensation committee of our board of directors granted to our employees options to purchase a total of 1,001,381 shares of our common stock at an exercise price of $48.00 per share. On the same date, certain of our non-employee directors received options to acquire a total of 70,562 shares of our common stock at an exercise price of $48.00 per share. The closing stock price on the effective date of the grants was $47.40 per share. The following tables summarize the details of options granted under our stock option plans that were still outstanding as of December 31, 2022, and the assumptions used to value those grants. All such grants were effective at the close of business on the date of grant. Options Option Exercise Closing Stock December 31, 2022 Date of Grant Options Options January 3, 2022 713,438 $ 62.00 $ 61.980 683,369 53,355 January 4, 2021 741,510 $ 48.00 $ 47.650 671,201 26,643 January 2, 2020 902,263 $ 38.00 $ 37.230 772,002 266,122 January 2, 2019 1,316,924 $ 26.00 $ 25.705 935,052 406,580 January 2, 2018 1,087,936 $ 27.50 $ 27.270 689,133 417,667 January 3, 2017 1,529,578 $ 23.50 $ 23.475 670,372 512,248 April 19, 2016 1,690,880 $ 23.00 $ 22.870 493,803 371,455 April 21, 2015 1,786,440 $ 21.00 $ 20.630 349,910 273,672 April 22, 2014 1,910,000 $ 28.00 $ 25.265 109,894 109,894 Total 11,678,969 5,374,736 2,437,636 Date of Grant Risk-free Expected Life Expected Expected Estimated Fair January 3, 2022 1.3% 5.00 1.7% 28.52 % $ 13.68 January 4, 2021 0.4% 5.00 2.0% 29.17 % $ 9.57 January 2, 2020 1.7% 5.00 2.4% 25.70 % $ 6.81 January 2, 2019 2.5% 5.00 2.9% 23.96 % $ 4.40 January 2, 2018 2.2% 5.00 2.3% 23.45 % $ 5.02 January 3, 2017 1.9% 5.00 2.6% 24.49 % $ 4.20 April 19, 2016 1.3% 5.00 2.6% 26.34 % $ 4.09 April 21, 2015 1.3% 5.00 2.7% 26.84 % $ 3.68 April 22, 2014 1.8% 5.00 2.0% 28.55 % $ 4.79 All of the options in the tables above vest and become exercisable over a period of up to eight years. Generally, each option will terminate approximat ely 10 years after the grant date. The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, net of forfeitures, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected stock volatilities are based on the movement of our stock price over the most recent historical period equivalent to the expected life of the option. A summary of activities under our stock option plans consisted of the following: Options Exercise Price (1) Remaining Life (2) Outstanding as of January 1, 2022 5,173,270 $ 30.23 6.08 Granted 713,438 $ 62.00 9.00 Exercised (346,992) $ 26.78 Cancelled/forfeited (164,980) $ 40.00 Outstanding as of December 31, 2022 5,374,736 $ 34.37 5.66 Exercisable as of December 31, 2022 2,437,636 $ 27.14 4.30 Options Exercise (1) Remaining Life (2) Outstanding as of January 1, 2021 5,914,757 $ 26.73 6.22 Granted 741,510 $ 48.00 9.00 Exercised (1,305,107) $ 24.34 Cancelled/forfeited (177,890) $ 31.22 Outstanding as of December 31, 2021 5,173,270 $ 30.23 6.08 Exercisable as of December 31, 2021 1,693,805 $ 25.11 4.68 (1) Weighted average exercise price. (2) Weighted average remaining contractual life in years. The total intrinsic value of stock options exercised during the years ended December 31, 2022, 2021, and 2020 was $10.2, $38.8, and $26.7, respectively. The intrinsic value represents the difference between the exercise price and fair value of the underlying shares at the date of exercise. At December 31, 2022, there was $14.5 of total unrecognized stock-based compensation expense related to outstanding unvested stock options granted under the employee stock option plan. This expense is expected to be recognized over a weighted average period of 4.07 years. Any future change in estimated forfeitures will impact this amount. The total grant date fair value of stock options vested under our employee stock option plan during 2022, 2021, and 2020 was $5.2, $4.8, and $6.1, respectively. Total stock-based compensation expense related to our employee stock option plan was $7.2, $5.6, and $5.7 for 2022, 2021, and 2020, respectively. Shares Outstanding Shares of common stock outstanding were as follows: 2022 2021 2020 Balance at beginning of year 575,464,682 574,159,575 574,128,911 Stock options exercised 346,992 1,305,107 1,630,664 Purchases of common stock (5,000,000) — (1,600,000) Balance at end of year 570,811,674 575,464,682 574,159,575 Earnings Per Share The following tables present a reconciliation of the denominators used in the computation of basic and diluted earnings per share and a summary of the options to purchase shares of common stock which were excluded from the diluted earnings calculation because they were anti-dilutive: Reconciliation 2022 2021 2020 Basic weighted average shares outstanding 573,777,790 574,808,030 573,778,761 Weighted shares assumed upon exercise of stock options 1,845,324 2,309,026 1,893,193 Diluted weighted average shares outstanding 575,623,114 577,117,056 575,671,954 Summary of Anti-dilutive Options Excluded 2022 2021 2020 Options to purchase shares of common stock 1,335,898 678,310 846,041 Weighted average exercise prices of options $ 55.25 48.00 38.00 Any dilutive impact summarized above related to periods when the average market price of our stock exceeded the exercise price of the potentially dilutive stock options then outstanding. |